David J. King
Overview
David J. King received an average of $633K in total compensation, including $302K in salary, at aTYR PHARMA between 2017 and 2018.
Source: SEC filings on March 28, 2019 and April 3, 2018.
Related executives
We found nine more executives who work or worked at aTYR PHARMA.
Sanjay Shukla
aTYR PHARMA
Chief Executive Officer
Jill Broadfoot
aTYR PHARMA
Chief Financial Officer
Nancy Denyes
aTYR PHARMA
General Counsel
Ashraf Amanullah
aTYR PHARMA
Former Senior Vice President, Biologics, Development and Manufacturing
John Mendlein
aTYR PHARMA
Chief Executive Officer
Sanuj Ravindran
aTYR PHARMA
Former Chief Business Officer
Kelly Blackburn
aTYR PHARMA
Vice President, Clinical Affairs
David Weiner
aTYR PHARMA